New Glu Research Opportunity

We’re partnering with our friends at Tidepool to study how daily highs and lows might affect the health and well-being of people with type 1 diabetes.

Articles

Medtronic sent notice to customers who use the MiniMed Revel and the MiniMel 530G in September.

Happy Birthday, Dr. Frederick Banting!

You can sign an e-birthday card to the scientist who brought insulin therapy into the medical world, and you can help try and break a Guinness World Record for greeting card signatures, thanks to this fun campaign by our friends at Beyond Type 1.

Jeff Hitchcock, a longtime advocate for the diabetes community, leads the T1D Exchange’s Patient/Parent Advisory Board for the QI Collaborative

We asked T1D Exchange Glu respondents how low their blood sugar levels had to go before they felt symptoms of a low. See the results and consider giving to our November campaign.

The pump maker has announced a collaboration with Samsung to bring this idea to market.

myglu.org and t1dexchange.org get a whole new look and improved features to better serve the type 1 diabetes communities.

New website puts patients at the center of accelerating innovation and improving care.

In the recent study, researchers find those who used Afrezza spent less time in hypoglycemia, and that some spent more time in range and less time in hyperglycemia.

See the results of this poll of over 300 Glu community members affected by type 1 diabetes. We present this as part of our "#YouToldGlu: 30 Facts, 30 Days" campaign.

Tandem and Medtronic both expect to roll out the pump systems in the last quarter of 2018.